Skip to content

Comparing Exposure v Imagery Rescripting in People With OCD: a SCED

Comparing Exposure v Imagery Rescripting in People With Obsessive Compulsive Disorder (OCD): a Single Case Experimental Design (SCED)

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06944366
Enrollment
6
Registered
2025-04-25
Start date
2024-08-30
Completion date
2026-04-30
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obsessive-Compulsive Disorder (OCD)

Brief summary

Individuals with OCD may experience intrusive future orientated thoughts and images, which are extremely distressing and interfering in life. This project aims to explore whether imagery rescripting or exposure may be a more effective intervention for individuals with OCD experiencing such images.

Interventions

Imagery rescripting or imaginal exposure

Sponsors

King's College London
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years or over * Main diagnosis of OCD (assessed by the Structured Clinical Interview for ICD11) * Must report future orientated images that are distressing and ego-dystonic

Exclusion criteria

* Psychosis, bipolar disorder, or trauma disorder * Current stimulant or hallucinogenic misuse, alcohol or substance misuse or dependence * Intellectual disability, dementia, serious cognitive impairment, or organic brain disorder * Personality Disorder as the main problem * Active suicidality * Concurrent engagement in other psychotherapy * A patient may be taking anti-depressant medication so long as the dose has been stable for 6 weeks and there is no plan to increase the dose.

Design outcomes

Primary

MeasureTime frameDescription
Obsessive Compulsive Inventory (OCI).From the start of treatment until the end of treatment at 12 weeks.A 42-item self-report scale to assess the severity and type of OCD symptoms; the OCI uses a 5-point Likert scale ranging from 0 (not at all) to 4 (extremely) and measures distress relating to 7 different subscales (washing, checking, doubting, ordering, obsessions, hoarding, and mental neutralizing). The total summed score of all items ranged between zero and 168. This measure will be completed at the beginning and end of each phase. Higher scores suggest more severe OCD symptomology.
Yale-Brown Obsessive-Compulsive scale (Y-BOCS).From the start of treatment until the end of treatment at 12 weeks.A 10-item self-rated scale used to measure the severity of obsessive-compulsive symptoms and response to treatment; each item is scored from 0 (no symptoms) to 4 (extreme symptoms), with a total ranging from zero to 40. It will be completed at the beginning and end of each phase. Higher scores suggest more severe OCD symptomatology.
The Impact of Future Events Scale (IFES).From the start of treatment until the end of treatment at 12 weeks.A 24-item self-rating scale used to measure the impact of intrusive prospective, personally relevant imagery. Each item is scored from 0 (no symptoms) to 4 (extreme symptoms), with a total ranging from zero to 96. Higher scores indicate greater symptomatology. This will be completed at the beginning and end of each phase.
The Florida Obsessive Compulsive Inventory (FOCI).From the start of treatment until the end of treatment at 12 weeks.Designed to measure the severity and frequency of obsessive-compulsive symptoms in individuals. The severity scale (Part B) of the FOCI was used in the project. Part B is a 5-item self-rating scale used to measure the frequency, severity, and impact of obsessive-compulsive symptoms; each item is scored from 0 (no symptoms) to 4 (extreme symptoms), with a total ranging from zero to 20. Higher scores indicate greater symptomology.
Visual Analogue Scales (VAS).From the start of treatment until the end of treatment at 12 weeks.Five daily self-report scales to be designed by the researchers using fixed scale (0=not at all; 10=extremely) answers to measure the following: Frequency of future orientated imagery Severity of future orientated imagery Vividness of future orientated imagery Degree of distress and aversive emotions associated with such imagery The urge to engage in compulsions/to neutralise the imagery.

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 23, 2026